GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has ...

It has been about a month since the last earnings report for Inogen (INGN). Shares have lost about 4.2% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the fourth quarter and the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid first-quarter 2024 ...

Q1 2026 Management view "Q1 came in at $85.1 million in total revenue, representing 3.4% year-over-year growth ahead of our expectations" (President, CEO & Director Kevin Smith). "International sales ...

BEVERLY, Mass. - Inogen reported total revenue of $85.1 million for the first quarter of 2026, a 3.4% increase compared to the prior-year period, ahead of the company’s expectations.

(1) Income tax impact of adjustments represents the tax impact related to the non-GAAP adjustments listed above and reflects an effective tax rate of 0% for 2025 and 2024. The articles, information, ...